1
David Sherrer
William D Houck, David W Sherrer: Three-dimensional microstructures and methods of formation thereof. Rohm and Haas Electronic Materials, Jonathan D Baskin, Rohm and Haas Electronic Materials, August 21, 2008: US20080197946-A1

Provided are three-dimensional microstructures and their methods of formation. The microstructures are formed by a sequential build process and include microstructural elements which are affixed to one another. The microstructures find use, for example, in coaxial transmission lines for electromagne ...


2
Eric First, M.D.
Eric R First: Methods for treating eye disorders. Allergan, Allergan, August 21, 2008: US20080199498-A1

The present invention provides methods of treating an eye disorder. The methods comprise a step of locally administering a Clostridial toxin to the eye of a patient to treat the disorder. The eye disorder may be associated with an inflammation of the eye, including for example, bacterial conjunctivi ...


3
Stokes Michael J, Stefanchik David: Flexible endoscope shapelock. Ethicon Endo Surgery, Stokes Michael J, Stefanchik David, JOHNSON Philip S, August 21, 2008: WO/2008/101080 (243 worldwide citation)

A medical apparatus includes a flexible sheath adapted to receive an endoscope. A first flexible rail is formed on the flexible sheath. The first flexible rail extends longitudinally along the length of the flexible sheath. A first rigidizable guide member includes a first track channel adapted to r ...


4
Stahler Gregory J, Wallace Daniel T, Salisbury J Kenneth: Robotic medical instrument system. Hansen Medical, Stahler Gregory J, Wallace Daniel T, Salisbury J Kenneth, BURSE David T, August 21, 2008: WO/2008/101228 (197 worldwide citation)

An instrument driver operable to control catheter instruments. First and second carriages are movably coupled to a frame of an instrument driver. Each carriage is configured to support a catheter instrument. The first and second carriages are independently rotatable about a longitudinal axis of the ...


5
Lang Philipp: Implant device and method for manufacture. Conformis, Lang Philipp, SAUNDERS Steven G, August 21, 2008: WO/2008/101090 (151 worldwide citation)

A knee implant includes a femoral component having first and second femoral component surfaces. The first femoral component surface is for securing to a surgically prepared compartment of a distal end of a femur. The second femoral component surface is configured to replicate the femoral condyle. Th ...


6
Bhat Balkrishen, Migawa Michael T, Swayze Eric E: 5-substituted-2-f modified nucleosides and oligomeric compounds prepared therefrom. Isis Pharmaceuticals, Bhat Balkrishen, Migawa Michael T, Swayze Eric E, RIEGER Dale, August 21, 2008: WO/2008/101157 (75 worldwide citation)

The present invention provides 5'-substituted-2'-F nucleoside analogs and oligomeric compounds comprising these nucleoside analogs. In one preferred embodiment the nucleoside analogs have either (R) or (5)-chirality at the 5'-position. These nucleoside analogs are expected to be useful for enhancing ...


7
Hafezi Hooman, Robertson Timothy, Snyder Eric, Cozad Brad: In-body power source having high surface area electrode. Proteus Biomedical, Hafezi Hooman, Robertson Timothy, Snyder Eric, Cozad Brad, FIELD Bret, August 21, 2008: WO/2008/101107 (75 worldwide citation)

Power sources that enable in-body devices, such as implantable and ingestible devices, are provided. Aspects of the in-body power sources of the invention include a solid support, a first high surface area electrode and a second electrode. Embodiments of the in-power sources are configured to emit a ...


8
Day Jonathan, Patterson James, Chabenne Joseph, Dimarchi Maria, Smiley David, Dimarchi Richard D: Glucagon/glp-1 receptor co-agonists. Indiana Unversity Research And Technology Corporation, Day Jonathan, Patterson James, Chabenne Joseph, Dimarchi Maria, Smiley David, Dimarchi Richard D, ADDISON Bradford G, August 21, 2008: WO/2008/101017 (71 worldwide citation)

Modified glucagon peptides are disclosed having enhanced potency at the glucagon receptor relative to native glucagon. Further modification of the glucagon peptides by forming lactam bridges or the substitution of the terminal carboxylic acid with an amide group produces peptides exhibiting glucagon ...


9
Locke Christopher Brian, Beard Mark Stephen James: System and method for managing reduced pressure at a tissue site. Kci Licensing, Locke Christopher Brian, Beard Mark Stephen James, MASON Robert W, August 21, 2008: WO/2008/100440 (70 worldwide citation)

The illustrative embodiments described herein are directed to an apparatus and method for managing reduced pressure at a tissue site. The apparatus includes a reduced pressure source that generates reduced pressure. The reduced pressure is delivered to the tissue site via a delivery tube. The appara ...


10
Sturmer Ryan A, Pollack Michael G, Pamula Vamsee K, Srinivasan Vijay, Paik Philip Y: Capacitance detection in a droplet actuator. Advanced Liquid Logic, Sturmer Ryan A, Pollack Michael G, Pamula Vamsee K, Srinivasan Vijay, Paik Philip Y, MILLS E Eric, August 21, 2008: WO/2008/101194 (63 worldwide citation)

A method, circuit and apparatus for detecting capacitance on a droplet actuator, inter alia, for determining the presence, partial presence or absence of a droplet at an electrode on a droplet actuator by: (a) providing a droplet actuator comprising: (i) a substrate comprising electrodes arranged on ...